Wound myiasis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:165955B87.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Wound myiasis (also known as traumatic myiasis or surgical wound myiasis) is a parasitic infestation in which fly larvae (maggots) infest open wounds, ulcers, or other skin lesions. It is classified under the broader category of myiasis (infestation of living tissue by dipterous fly larvae). The condition occurs when certain species of flies — including Cochliomyia hominivorax (New World screwworm), Chrysomya bezziana (Old World screwworm), Lucilia sericata, Wohlfahrtia magnifica, and other species — deposit their eggs or larvae in pre-existing wounds, surgical sites, or areas of damaged skin. The larvae feed on necrotic or living tissue, causing progressive tissue destruction, inflammation, pain, and secondary bacterial infection. The condition primarily affects the skin and soft tissues but can extend to deeper structures including muscle, cartilage, and bone if left untreated. Key clinical features include the presence of visible larvae within the wound, a sensation of movement or crawling, pain, foul-smelling discharge, tissue necrosis, and surrounding inflammation. Patients may also experience fever and systemic symptoms if secondary infection develops. Wound myiasis is more common in tropical and subtropical regions and disproportionately affects individuals with poor wound care, impaired mobility, homelessness, neglected elderly patients, and those with chronic debilitating conditions or poor hygiene. Treatment involves mechanical removal of all larvae from the wound, thorough debridement of necrotic tissue, wound irrigation, and appropriate wound care. Topical application of substances such as petroleum jelly, turpentine, or chloroform may be used to suffocate larvae and facilitate their extraction. Systemic antibiotics are administered when secondary bacterial infection is present. Oral ivermectin has been used as an adjunctive treatment in some cases. Prevention focuses on proper wound management, use of protective dressings, insect repellents, and fly control measures. With prompt and appropriate treatment, the prognosis is generally good, though delayed treatment can lead to significant tissue destruction and complications.

Also known as:

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Wound myiasis.

View clinical trials →

No actively recruiting trials found for Wound myiasis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Wound myiasis community →

No specialists are currently listed for Wound myiasis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Wound myiasis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Wound myiasisForum →

No community posts yet. Be the first to share your experience with Wound myiasis.

Start the conversation →

Latest news about Wound myiasis

No recent news articles for Wound myiasis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Wound myiasis

What is Wound myiasis?

Wound myiasis (also known as traumatic myiasis or surgical wound myiasis) is a parasitic infestation in which fly larvae (maggots) infest open wounds, ulcers, or other skin lesions. It is classified under the broader category of myiasis (infestation of living tissue by dipterous fly larvae). The condition occurs when certain species of flies — including Cochliomyia hominivorax (New World screwworm), Chrysomya bezziana (Old World screwworm), Lucilia sericata, Wohlfahrtia magnifica, and other species — deposit their eggs or larvae in pre-existing wounds, surgical sites, or areas of damaged skin.